0001209191-21-045638.txt : 20210706 0001209191-21-045638.hdr.sgml : 20210706 20210706184733 ACCESSION NUMBER: 0001209191-21-045638 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210701 FILED AS OF DATE: 20210706 DATE AS OF CHANGE: 20210706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLD DANIEL P PHD CENTRAL INDEX KEY: 0001288233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 211075671 MAIL ADDRESS: STREET 1: 10445 PACIFIC CENTER CT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-369-7100 MAIL ADDRESS: STREET 1: 11455 EL CAMINO REAL STREET 2: SUITE 250 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-01 0 0001262104 MEI Pharma, Inc. MEIP 0001288233 GOLD DANIEL P PHD C/O MEI PHARMA, INC. 11455 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Common Stock 2021-07-02 4 F 0 41320 2.94 D 417312 D Stock Option (Right to Buy) 2.95 2021-07-01 4 A 0 855000 0.00 A 2031-07-01 Common Stock 855000 855000 D Stock Option (Right to Buy) 1.57 2025-07-28 Common Stock 275500 275500 D Stock Option (Right to Buy) 1.36 2026-07-29 Common Stock 380000 380000 D Stock Option (Right to Buy) 2.83 2027-07-06 Common Stock 380000 380000 D Stock Option (Right to Buy) 4.33 2028-06-22 Common Stock 380000 380000 D Stock Option (Right to Buy) 4.28 2028-07-12 Common Stock 300000 300000 D Stock Option (Right to Buy) 2.52 2029-07-01 Common Stock 675000 675000 D Stock Option (Right to Buy) 3.49 2030-07-02 Common Stock 680000 680000 D Represents the number of shares withheld by and surrendered to the Issuer on July 2, 2021, to satisfy tax withholding obligations that arose in connection with the delivery of shares underlying restricted stock units. One-quarter of such options shall vest on July 1, 2022 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2022. All of such options are presently exercisable. One-quarter of such options vested on July 6, 2018 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 6, 2018. One-quarter of such options vested on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019. One-quarter of such options vested on July 12, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 12, 2019. One-quarter of such options vested on July 1, 2020 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 1, 2020. One-quarter of such options vested on July 2, 2021 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on July 2, 2021. /s/ Brian G. Drazba, as attorney in fact 2021-07-06